New Zealand markets closed

Sanofi (SAN.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
85.14-1.63 (-1.88%)
At close: 05:39PM CET
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
44,348,000
39,175,000
37,369,000
37,631,000
Cost of revenue
13,436,000
12,255,000
12,157,000
11,976,000
Gross profit
30,912,000
26,920,000
25,212,000
25,655,000
Operating expenses
Research development
6,468,000
5,692,000
5,529,000
6,018,000
Selling general and administrative
10,355,000
9,555,000
9,390,000
9,883,000
Total operating expenses
19,577,000
17,773,000
17,319,000
18,429,000
Operating income or loss
11,335,000
9,147,000
7,893,000
7,226,000
Interest expense
420,000
403,000
436,000
444,000
Total other income/expenses net
-3,279,000
-1,016,000
6,248,000
-4,101,000
Income before tax
7,762,000
7,798,000
13,804,000
2,822,000
Income tax expense
1,370,000
1,558,000
1,813,000
139,000
Income from continuing operations
6,475,000
6,279,000
12,350,000
2,938,000
Net income
6,409,000
6,223,000
12,314,000
2,806,000
Net income available to common shareholders
6,409,000
6,223,000
12,314,000
2,806,000
Basic EPS
-
4.97
9.82
2.24
Diluted EPS
-
4.97
9.82
2.24
Basic average shares
-
1,252,500
1,253,600
1,249,900
Diluted average shares
-
1,252,500
1,253,600
1,249,900
EBITDA
-
11,552,000
17,924,000
10,718,000